REGULATED PRESS RELEASE published on 11/12/2024 at 08:47, 9 days 4 hours ago Laboratoires Euromedis - Lancement d'une OCA avec maintien du DPS
BRIEF published on 10/28/2024 at 18:23, 23 days 18 hours ago Euromedis Groupe : Résultats Semestriels 2024 Chiffre D'affaires Résultats Semestriels Marge Brute Géopolitique Euromedis
BRIEF published on 10/28/2024 at 18:23, 23 days 18 hours ago Euromedis Group: Half-Year Results 2024 Gross Margin Half-year Results Turnover Geopolitics Euromedis
BRIEF published on 10/28/2024 at 18:20, 23 days 18 hours ago Analyse du Rapport Financier Semestriel de Laboratoires Euromedis au 30 juin 2024 Chiffre D'affaires Reorganisation Laboratoires Euromedis Finances Semestrielles Coûts De Transport
BRIEF published on 10/28/2024 at 18:20, 23 days 18 hours ago Analysis of the Euromedis Laboratories Half-Year Financial Report as of June 30, 2024 Reorganization Turnover Half-yearly Finances Euromedis Laboratories Transportation Costs
REGULATED PRESS RELEASE published on 10/28/2024 at 18:18, 23 days 19 hours ago Euromedis - Communiqué semestriel 2024 Annonce des résultats semestriels 2024 de Laboratoires Euromedis après fusion avec Euromedis Groupe, soulignant l'effet des tensions géopolitiques et les perspectives de réorganisation pour le second semestre Tensions Géopolitiques Résultats Semestriels 2024 Fusion Sociétés Réorganisation Société Perspectives Second Semestre 2024
REGULATED PRESS RELEASE published on 10/28/2024 at 18:15, 23 days 19 hours ago Rapport Financier Semestriel - 30/06/2024 Rapport financier semestriel de SA Laboratoires Euromedis pour le 30 juin 2024, incluant les comptes, événements marquants, risques et perspectives. Fusion avec Euromedis Groupe. Analyse des résultats et prévisions Perspectives Rapport Financier Comptes Semestriels 30 Juin 2024 SA Laboratoires Euromedis
REGULATED PRESS RELEASE published on 04/30/2024 at 18:25, 6 months 20 days ago Rapport financier annuel 2023
BRIEF published on 04/26/2024 at 18:53, 6 months 24 days ago Euromedis Groupe publie ses résultats annuels pour 2023 Prévisions 2024 Résultats Financiers 2023 Impact Géopolitique Euromedis Groupe Fusion Entreprise
BRIEF published on 04/26/2024 at 18:53, 6 months 24 days ago Euromedis Groupe publishes its annual results for 2023 2023 Financial Results Forecast 2024 Geopolitical Impact Euromedis Group Company Merger
Published on 11/21/2024 at 13:00, 19 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 19 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 19 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 19 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 19 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 44 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 4 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 11:30, 1 hour 49 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 06:58, 6 hours 21 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 21 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 21 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 17 hours 12 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 59 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
